WO2007095977A1 - Food product and process for preparing it - Google Patents
Food product and process for preparing it Download PDFInfo
- Publication number
- WO2007095977A1 WO2007095977A1 PCT/EP2006/009532 EP2006009532W WO2007095977A1 WO 2007095977 A1 WO2007095977 A1 WO 2007095977A1 EP 2006009532 W EP2006009532 W EP 2006009532W WO 2007095977 A1 WO2007095977 A1 WO 2007095977A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pullulan
- glucose
- food product
- carbohydrate
- molecular weight
- Prior art date
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 40
- 238000004519 manufacturing process Methods 0.000 title description 7
- 229920001218 Pullulan Polymers 0.000 claims abstract description 56
- 235000019423 pullulan Nutrition 0.000 claims abstract description 56
- 239000004373 Pullulan Substances 0.000 claims abstract description 55
- 150000001720 carbohydrates Chemical class 0.000 claims description 37
- 239000000047 product Substances 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 8
- 230000000694 effects Effects 0.000 claims description 5
- 235000014347 soups Nutrition 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 2
- 235000015067 sauces Nutrition 0.000 claims description 2
- 239000012263 liquid product Substances 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 42
- 239000008103 glucose Substances 0.000 description 41
- 235000014633 carbohydrates Nutrition 0.000 description 35
- 229920002472 Starch Polymers 0.000 description 18
- 235000019698 starch Nutrition 0.000 description 18
- 239000008107 starch Substances 0.000 description 17
- 230000007062 hydrolysis Effects 0.000 description 15
- 238000006460 hydrolysis reaction Methods 0.000 description 15
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 230000002641 glycemic effect Effects 0.000 description 10
- 210000000813 small intestine Anatomy 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 230000029087 digestion Effects 0.000 description 9
- 108090000637 alpha-Amylases Proteins 0.000 description 8
- 230000004044 response Effects 0.000 description 8
- 239000012634 fragment Substances 0.000 description 7
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 6
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 5
- 108010065511 Amylases Proteins 0.000 description 5
- 102000013142 Amylases Human genes 0.000 description 5
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 5
- 235000019418 amylase Nutrition 0.000 description 5
- 230000015556 catabolic process Effects 0.000 description 5
- 238000006731 degradation reaction Methods 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 239000004382 Amylase Substances 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 210000001072 colon Anatomy 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 230000000291 postprandial effect Effects 0.000 description 4
- 230000036186 satiety Effects 0.000 description 4
- 235000019627 satiety Nutrition 0.000 description 4
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 150000002016 disaccharides Chemical class 0.000 description 3
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 2
- 102100031126 6-phosphogluconolactonase Human genes 0.000 description 2
- 108010029731 6-phosphogluconolactonase Proteins 0.000 description 2
- 229920000945 Amylopectin Polymers 0.000 description 2
- 229920000856 Amylose Polymers 0.000 description 2
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 2
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 2
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 2
- 102000005548 Hexokinase Human genes 0.000 description 2
- 108700040460 Hexokinases Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 206010025476 Malabsorption Diseases 0.000 description 2
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 2
- 108010026867 Oligo-1,6-Glucosidase Proteins 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 235000021257 carbohydrate digestion Nutrition 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 210000001198 duodenum Anatomy 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 206010016766 flatulence Diseases 0.000 description 2
- 230000030136 gastric emptying Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 229940045189 glucose-6-phosphate Drugs 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 210000001630 jejunum Anatomy 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 2
- 235000021486 meal replacement product Nutrition 0.000 description 2
- 210000000110 microvilli Anatomy 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- VZOPRCCTKLAGPN-ZFJVMAEJSA-L potassium;sodium;(2r,3r)-2,3-dihydroxybutanedioate;tetrahydrate Chemical compound O.O.O.O.[Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O VZOPRCCTKLAGPN-ZFJVMAEJSA-L 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 2
- WDMUXYQIMRDWRC-UHFFFAOYSA-N 2-hydroxy-3,4-dinitrobenzoic acid Chemical compound OC(=O)C1=CC=C([N+]([O-])=O)C([N+]([O-])=O)=C1O WDMUXYQIMRDWRC-UHFFFAOYSA-N 0.000 description 1
- LWFUFLREGJMOIZ-UHFFFAOYSA-N 3,5-dinitrosalicylic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1O LWFUFLREGJMOIZ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 108010001394 Disaccharidases Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 102400000471 Isomaltase Human genes 0.000 description 1
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 102000001746 Pancreatic alpha-Amylases Human genes 0.000 description 1
- 108010029785 Pancreatic alpha-Amylases Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 102100027918 Sucrase-isomaltase, intestinal Human genes 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 239000002535 acidifier Substances 0.000 description 1
- 230000036626 alertness Effects 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 239000012490 blank solution Substances 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013058 crude material Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 235000011850 desserts Nutrition 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000036997 mental performance Effects 0.000 description 1
- 230000004066 metabolic change Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000004886 process control Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000011006 sodium potassium tartrate Nutrition 0.000 description 1
- 229940074446 sodium potassium tartrate tetrahydrate Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 235000012794 white bread Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
- A23L29/274—Pullulan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the invention relates to food products. More in particular, it relates to a carbohydrate containing food product having controlled or delayed energy release properties and to a process for preparing such product.
- the optimal diet to maintain health comprises at least 55% total energy from a variety of carbohydrate sources. Cereals with high starch content provide the main source of carbohydrates worldwide. Many other food products comprise starch, such as bread, pasta, and potatoes.
- Starch is a homopolymer of glucose. It consists of essentially linear amylose molecules and highly branched amylopectin molecules. Starch can be rapidly converted to glucose in the intestinal tract. The glucose then enters the blood stream and provides the body with energy. In humans, starch degradation is initiated by the action of alpha-amylase in the saliva. The digestion of the remaining starch molecules is continued by the actions of pancreatic alpha-amylases . In general, pancreatic amylase is more important for digestion because food generally does not remain in the mouth long enough to be digested thoroughly by salivary amylase.
- Hydrolysis of starch is completed in the duodenum and jejunum by the action of pancreatic amylase, which hydrolyses amylose to maltose and maltotriose and amylopectin to a mixture of maltose, isomaltose, and alpha-limit dextrins (three to five glucose units [alpha-1,4] and one glucose unit [alpha-1, 6] ) .
- pancreatic amylase hydrolyses amylose to maltose and maltotriose and amylopectin to a mixture of maltose, isomaltose, and alpha-limit dextrins (three to five glucose units [alpha-1,4] and one glucose unit [alpha-1, 6] ) .
- Final hydrolysis of these products is then carried out by the oligosaccharide-degrading enzymes amyloglucosidase (glucan 1,4- alpha-glucosidase) and isomaltas
- the rate of digestion is the major determinant of glycaemia in the case of carbohydrate-rich (e.g. starchy) foods.
- carbohydrate delivery should be controlled.
- a constant blood glucose level is beneficial, whereby the glucose release is slower, but sustained for longer.
- Englyst et al. (Englyst KN, Englyst HN, Hudson GJ, Cole TJ, Cummings JH. Rapidly available glucose in foods: an in vitro measurement that reflects the glycaemic response.
- pullulan reaching the colon undigested will be fermented by present micro-organisms and this might cause malabsorption and associated gastro-intestinal symptoms like flatulence.
- the invention provides a carbohydrate containing food product having controlled energy release properties comprising a pullulan having a number average molecular weight between about 1,000 and 45,000 daltons.
- the invention relates to a food product having "controlled" energy release properties.
- GI glycaemic index
- RAC rapidly available carbohydrates
- SAC slowly available carbohydrates
- Resistant carbohydrate is the sum of carbohydrate and products of carbohydrate degradation that are not absorbed in the small intestine of healthy humans. RC therefore reaches the colon where it can be fermented by present micro-organisms and where it can play a role in the maintenance of human digestive health.
- the determinants of post-prandial glucose excursions are numerous and include the amount and nature of the carbohydrates ingested, the rate of gastric emptying, the rates of intraluminal carbohydrate digestion and of intestinal glucose absorption, the entero-pancreatic hormonal response, and specific postabsorptive metabolic changes. Of these processes the rates of gastric emptying and digestion/ absorption are the most important ones.
- the rate of digestion is the major determinant of glycaemia in the case of carbohydrate-rich foods. Differences in glycaemic responses to dietary carbohydrate are directly related to the rate of carbohydrate digestion.
- carbohydrates are digested and 95% absorbed in the first part of the small intestine (duodenum and jejunum). In the first steps of digestion and absorption the physico-chemical characteristics of carbohydrates determine the rate and extent of these processes.
- An example is the fact that an ⁇ -1,4 bond is easier to digest than an ⁇ -1,6 bond.
- slowly available carbohydrate or, specifically for glucose-polymers slowly available glucose (SAG) is likely to be completely digested in the small intestine but at a slower rate, resulting in lower blood glucose levels that are maintained for a longer time.
- rapidly available glucose RAG is glucose-polymers that are quickly hydrolysed, which results in high blood glucose concentrations, which are maintained for only a relatively short time.
- the in vitro measurement of RAG and SAG could predict the glycaemic response measured in human studies.
- Englyst et al. defined RAG in the in vitro situation by the amount of carbohydrate hydrolysed to glucose after 20 min (called G20) . Also the amount hydrolysed was measured after 120 minutes (called G120) . The amount hydrolysed during these 120 minutes was considered to be available for absorption in the small intestine. Anything hydrolysed after the 120 min was considered not available for absorption and considered resistant.
- the amount of carbohydrates hydrolysed between 20 and 120 min i.e. G120 - G20 was defined as SAG.
- controlled energy release as the release of carbohydrates represented by an in vitro hydrolysis (curve) , where G120- G20 is significantly higher than in a proper control that contains the same amount of available carbohydrate, while G120 is as high as possible, i.e. at least 50, 65, 80 or even 90% of the theoretical maximum.
- rapidly digestible carbohydrates e.g. starch, glucose, sucrose
- Pullulan is a fermentation product of the yeast Aerobasidium pullulans. In the food industry, pullulan is applied as a texturiser. It is a water-soluble, viscous polysaccharide consisting of three ⁇ -1,4 linked glucose molecules (one maltotriose-unit) that are repeatedly polymerised by an ⁇ -1,6 linkage on the terminal glucose, resulting in a stair-step structure (see Fig. 1) .
- Pullulan has a molecular weight of 50,000 and 500,000 Dalton. It has the properties of a soluble fiber, i.e. it is resistant against enzymatic hydrolysis by intestinal enzymes and upon ingestion the major part of it reaches the colon undigested. The reason for the low degree of hydrolysis is that intestinal enzymes only have a limited capacity to hydrolyse the ⁇ -1,6 linkages of the polymer.
- pancreatic enzymes lack the specificity to break down the ⁇ -1,6 linkages of the polymer.
- a reduction in the chain length of pullulan - by breaking part of the ⁇ -1,6 bonds via pretreatment by pullulanase - was more readily hydrolysable.
- pullulan fragments of predetermined chain lengths can be achieved in several ways.
- process control is an effective way to control the chain length of microbially produced pullulan.
- factors like, culture selection, cultivation techniques and control of incubation conditions, like pH or substrate are known to have a significant effect on the chain length distribution of biosynthetic pullulan.
- fructose in the culture medium promotes the production of high molecular weight pullulan.
- Another important factor is the harvest time, since early in the initial phases of biosynthesis high molecular weight pullulan with a wide chain length distribution is produced, while more pullulan of medium chain length and narrow chain length distribution is produced in the stationary growth phase.
- pullulan with a specific chain length can be obtained by fractionation of crude material with a wider chain length distribution. This may be achieved by e.g. size exclusion techniques.
- Thirdly pullulan fragments with a defined chain length distribution can be obtained via partial hydrolysis of pullulan. For instance, pullulan P-200 (commercially available from Hayashibara Biochemical Laboratories, Japan) can be treated with the enzyme pullulanase that selectively hydrolyses alpha 1-6 bonds of the molecule. By careful control of the incubation conditions fractions with desired chain length ranging from about 1,000 to 100,000 daltons can be obtained.
- the specific type of pullulan used according to the present invention has a number average molecular weight between about 1,000 and 45,000 daltons, preferably between about 5,000 and 40,000 daltons.
- average molecular weight we mean in the context of the present invention the number average molecular weight (M n ), unless indicated otherwise. It is preferred that at least 70%, more preferably at least 90% of the pullulan molecules have a molecular weight of less than 45,000 Dalton.
- the pullulan is present in the food product in an amount of 0.005 to 35% by weight of the product, more preferably in an amount of 0.05 to 10% by weight of the product .
- the food product according to the invention has a high moisture content.
- the water activity (Aw) is preferably at least 0.70.
- Some examples of food products in accordance with the present invention are: drinks / beverages, meal replacement products such as drinks, bars, powders, soups, dry soups, powdered soup concentrates, (fat) spreads, dressings, (whole) meals, desserts, sauces, sport drinks, fruit juices, snack foods, ready-to-eat and pre-packed meal products, ice creams and dried meal products.
- drink / beverages meal replacement products such as drinks, bars, powders, soups, dry soups, powdered soup concentrates, (fat) spreads, dressings, (whole) meals, desserts, sauces, sport drinks, fruit juices, snack foods, ready-to-eat and pre-packed meal products, ice creams and dried meal products.
- meal replacement products such as drinks, bars, powders, soups, dry soups, powdered soup concentrates, (fat) spreads, dressings, (whole) meals, desserts, sauces, sport drinks, fruit juices, snack foods, ready-to-eat and pre-packed meal products, ice
- the food products can be prepared by mixing the pullulan, in dry form or in the forms of an aqueous suspension, with the rest of the food product.
- the food product of the present invention may optionally further comprise ingredients such as proteins, fats, salts, flavour components, colourants, emulsifiers, preservatives, acidifying agents and the like.
- ingredients such as proteins, fats, salts, flavour components, colourants, emulsifiers, preservatives, acidifying agents and the like.
- DNSA dinitrosalicylic acid
- 500 ⁇ l of samples to be analysed was added to 500 ⁇ l DNSA solution and heated for about 5 minutes at 100 0 C in a thermomixer (Eppendorf thermomixer comfort) . After that, tubes containing the mixtures were cooled under running tap water or on ice. Solutions were diluted properly with H 2 O and the absorbances were measured at 540 nm (Shimadzu) . Standard concentrations of maltose (ranging from 0- 5 mg/ml) were prepared in 0.02 M phosphate buffer pH 6.9, containing 0.067 M NaCl. From the absorbances measured, maltose concentrations were calculated.
- Pullulan was treated with pullulanase (0.0, 0.1 and 1.0 U/ml) as described above.
- pullulanase (0.0, 0.1 and 1.0 U/ml) was added to 14 ml of the samples 1 ml of amyloglucosidase (from Aspergillus niger, Fluka 10115) was added and glucose release was monitored in time. From Figure 2 it is clear that the unhydrolysed pullulan hardly released any glucose upon amyloglucosidase treatment, whereas the partially hydrolysed fractions of pullulan gave a sustained release of glucose over the two hours of incubation.
- the glucose concentration of samples was measured using an enzymatic kit (Enzytec) .
- the measurement was based on the following principle: hexokinase D-glucose + ATf ⁇ Glucose-6-phosphate + ⁇ DP
- reaction was performed in 3 ml plastic cuvettes. To 1 ml of triethanolamine (TEA) buffer of pH 7.6, containing
Abstract
A food product having controlled energy release properties is provided comprising a pullulan having a number average molecular weight between about 1,000 and 45,000 daltons.
Description
FOOD PRODUCT AND PROCESS FOR PREPARING IT
FIELD OF THE INVENTION
The invention relates to food products. More in particular, it relates to a carbohydrate containing food product having controlled or delayed energy release properties and to a process for preparing such product.
BACKGROUND TO THE INVENTION
According to World Health Organisation recommendations, the optimal diet to maintain health comprises at least 55% total energy from a variety of carbohydrate sources. Cereals with high starch content provide the main source of carbohydrates worldwide. Many other food products comprise starch, such as bread, pasta, and potatoes.
Starch is a homopolymer of glucose. It consists of essentially linear amylose molecules and highly branched amylopectin molecules. Starch can be rapidly converted to glucose in the intestinal tract. The glucose then enters the blood stream and provides the body with energy. In humans, starch degradation is initiated by the action of alpha-amylase in the saliva. The digestion of the remaining starch molecules is continued by the actions of pancreatic alpha-amylases . In general, pancreatic amylase is more important for digestion because food generally does not remain in the mouth long enough to be digested thoroughly by salivary amylase.
Hydrolysis of starch is completed in the duodenum and jejunum by the action of pancreatic amylase, which hydrolyses amylose to maltose and maltotriose and amylopectin to a mixture of maltose, isomaltose, and alpha-limit dextrins (three to five glucose units [alpha-1,4] and one glucose unit [alpha-1, 6] ) .
Final hydrolysis of these products is then carried out by the oligosaccharide-degrading enzymes amyloglucosidase (glucan 1,4- alpha-glucosidase) and isomaltase (oligo 1,6 glucosidase) . These enzymes that complete the hydrolysis of starch are anchored to the brush-border membrane.
Next to starch, many products contain high amounts of monosaccharides (e.g. glucose, fructose) and disaccharides (e.g. sucrose, maltose, lactose) and to a lesser extent sugar alcohols, oligo (tri-) saccharides and other polysaccharides. Disaccharides are too large to cross the mucosal cell membrane and must be hydrolysed for absorption to take place. Disaccharidases are located in the brush borders of the intestinal mucosa. Hydrolysis of most disaccharides and starches in the upper small intestine is rapid.
However, there is increasing evidence that a high intake of food products leading to a high glycaemic (blood glucose) response has a deleterious effect on type-2 diabetes and cardiovascular disease. Diets leading to a low glycaemic response appear to be useful in the management of the metabolic syndrome and of hyperlipidaemia. Lowering of cholesterol levels has also been observed in healthy subjects and there are also indications of improvements in fibrinolytic activity.
Differences in the post-prandial glucose profile may also be of physiological significance for satiety and weight maintenance. Data regarding the satiating capacity in relation to glycaemic features are, however, not consistent. Some studies have shown that a modest glucose rise will increase insulin sensitivity. This may induce stronger feelings of satiety and thereby a lower energy intake.
Much less information is present regarding the potential impact of post-prandial glycaemic level on cognitive function and
mental performance. There are some studies to support a relationship between glucose availability and changes in mood and/or mental function ( 'energy' , 'alertness' , 'concentration' , 'reduced irritability' , 'reduced fatigue' , 'vitality' ) . The optimal blood glucose curve has yet to be defined.
The concept of 'energy' is used widely in the food industry. However, most 'energy' claims are not scientifically substantiated and the underlying technology is mostly generic. Furthermore, the concept is very much restricted to cereals and biscuits. For other applications in which the water content is higher and heat is applied in the production process, this approach will not work. For example, when starch granules are heated in the presence of water, gelatinization occurs, which renders the starch molecules fully accessible to digestive enzymes, resulting in rapidly digestible starch. Depending on the process, part of the starch might also turn into indigestible starch without nutritional value.
As indicated before, the rate of digestion is the major determinant of glycaemia in the case of carbohydrate-rich (e.g. starchy) foods. To deliver a desired energy delivery profile for specific health and performance benefits, the carbohydrate delivery should be controlled. For most benefits a constant blood glucose level is beneficial, whereby the glucose release is slower, but sustained for longer. In that respect, Englyst et al. (Englyst KN, Englyst HN, Hudson GJ, Cole TJ, Cummings JH. Rapidly available glucose in foods: an in vitro measurement that reflects the glycaemic response. American Journal of Clinical Nutrition (1999) 69:448-54.) define slowly digested carbohydrates (or "slow carbs") as "carbohydrates that are likely to be completely digested in the small intestine but at a slower rate".
US-A-3 875 308 (Hayashibara Biochemical Laboratories) discloses food products comprising at least 0.05% pullulan and having a reduced caloric value. Pullulan is considered to be digestible only to an insignificant extent and it is added to the food products to replace starch.
US-A-2003/0232067 (Bryan Wolf) discloses the use of pullulan having a molecular weight between 50,000 and 500,000 daltons, as a slowly digested carbohydrate and its incorporation into food products, especially beverages and meal replacement products. However, a significant part of the pullulan seemed to be either resistant to degradation, or the digestion of pullulan occurred too slowly to achieve" complete hydrolysis at the end of the small intestine. This part of the pullulan was therefore not available as a short-term source for energy (e.g. available within 2 hours) and not available for characteristics associated with energy delivery (e.g. effect of glucose on satiety) .
Furthermore, pullulan reaching the colon undigested will be fermented by present micro-organisms and this might cause malabsorption and associated gastro-intestinal symptoms like flatulence.
From a product formulation perspective, the use of pullulan is limited to lower concentrations. Higher concentrations, effective for energy supply will lead to liquid food products having unacceptable high viscosity.
It is therefore an object of the invention to provide a carbohydrate containing food product having controlled energy release properties and which overcomes one or more of the above mentioned draw-backs. Surprisingly, it has now been found that the above-mentioned object can be achieved by the carbohydrate
containing food product according to the invention, comprising a pullulan having a number average molecular weight between about 1,000 and 45,000 daltons.
SUMMARY OF THE INVENTION
According to a first aspect, the invention provides a carbohydrate containing food product having controlled energy release properties comprising a pullulan having a number average molecular weight between about 1,000 and 45,000 daltons.
According to a second aspect, there is provided a process for preparing such a food product.
DETAILED DESCRIPTION OF THE INVENTION
The invention relates to a food product having "controlled" energy release properties. There are now several ways to visualise and quantify the glycaemic effect of foods. The glycaemic index (GI) concept has been introduced to enable comparison of foods based on their glycaemic effect. It provides a standardised comparison for the 2 hour post-prandial glucose response of a carbohydrate with that of white bread or glucose .
Avoiding products that cause an immediate high blood sugar level will help to get a lower glucose response, but that can also be accomplished by "slow" carbohydrates. In that respect, one now speaks of rapidly available carbohydrates (RAC) or slowly available carbohydrates (SAC) . RAC is carbohydrate that is quickly hydrolysed, which results in high blood glucose concentrations, which are maintained for only a short time. SAC is defined as carbohydrate that is likely to be completely digested in the small intestine but at a slower rate, resulting
in lower blood glucose levels that are maintained for a longer time.
Resistant carbohydrate (RC) is the sum of carbohydrate and products of carbohydrate degradation that are not absorbed in the small intestine of healthy humans. RC therefore reaches the colon where it can be fermented by present micro-organisms and where it can play a role in the maintenance of human digestive health.
The determinants of post-prandial glucose excursions are numerous and include the amount and nature of the carbohydrates ingested, the rate of gastric emptying, the rates of intraluminal carbohydrate digestion and of intestinal glucose absorption, the entero-pancreatic hormonal response, and specific postabsorptive metabolic changes. Of these processes the rates of gastric emptying and digestion/ absorption are the most important ones. The rate of digestion is the major determinant of glycaemia in the case of carbohydrate-rich foods. Differences in glycaemic responses to dietary carbohydrate are directly related to the rate of carbohydrate digestion.
Most carbohydrates are digested and 95% absorbed in the first part of the small intestine (duodenum and jejunum). In the first steps of digestion and absorption the physico-chemical characteristics of carbohydrates determine the rate and extent of these processes. An example is the fact that an α-1,4 bond is easier to digest than an α-1,6 bond.
As indicated above, slowly available carbohydrate or, specifically for glucose-polymers, slowly available glucose (SAG) is likely to be completely digested in the small intestine but at a slower rate, resulting in lower blood
glucose levels that are maintained for a longer time. On the other hand, rapidly available glucose (RAG) is glucose-polymers that are quickly hydrolysed, which results in high blood glucose concentrations, which are maintained for only a relatively short time.
Englyst et al. (1999, see above) used an in vitro test that correlates significantly to the in vivo glucose curves. The in vitro measurement of RAG and SAG could predict the glycaemic response measured in human studies. Englyst et al. defined RAG in the in vitro situation by the amount of carbohydrate hydrolysed to glucose after 20 min (called G20) . Also the amount hydrolysed was measured after 120 minutes (called G120) . The amount hydrolysed during these 120 minutes was considered to be available for absorption in the small intestine. Anything hydrolysed after the 120 min was considered not available for absorption and considered resistant. The amount of carbohydrates hydrolysed between 20 and 120 min (i.e. G120 - G20) was defined as SAG. In the ideal situation one would like to have a carbohydrate with a very low G20 and a very high G120, resulting in a high difference between G20 and G120. However, many efforts in industry to make certain products slowly digestible render them (partly) resistant. As such one wants to keep G120 as close as possible to the theoretical maximum (i.e. 100% of the total amount of theoretically available carbohydrate) .
In the present invention, we define "controlled energy release" as the release of carbohydrates represented by an in vitro hydrolysis (curve) , where G120- G20 is significantly higher than in a proper control that contains the same amount of available carbohydrate, while G120 is as high as possible, i.e. at least 50, 65, 80 or even 90% of the theoretical maximum.
By varying the relative amounts and by combining rapidly digestible carbohydrates (e.g. starch, glucose, sucrose) and pullulan with the above-mentioned properties, the release properties of energy in a food product can be controlled.
We found that one route to slow down energy delivery from carbohydrates in the human gut is the use of pullulan having a specific molecular weight. Pullulan is a fermentation product of the yeast Aerobasidium pullulans. In the food industry, pullulan is applied as a texturiser. It is a water-soluble, viscous polysaccharide consisting of three α-1,4 linked glucose molecules (one maltotriose-unit) that are repeatedly polymerised by an α-1,6 linkage on the terminal glucose, resulting in a stair-step structure (see Fig. 1) .
Pullulan has a molecular weight of 50,000 and 500,000 Dalton. It has the properties of a soluble fiber, i.e. it is resistant against enzymatic hydrolysis by intestinal enzymes and upon ingestion the major part of it reaches the colon undigested. The reason for the low degree of hydrolysis is that intestinal enzymes only have a limited capacity to hydrolyse the α-1,6 linkages of the polymer.
Wolf et al. (Am. Soc. For Nutritional Sciences 0022-3166/03) showed that pullulan, in comparison with rapidly digestible maltodextrins, maintained blood glucose levels for a longer time above the basal level, which supported the hypothesis that
pullulan was digested slowly. However, a significant part of the pullulan seemed to be either resistant to degradation, or the digestion of pullulan occurred too slowly to achieve complete hydrolysis at the end of the small intestine. This part of the pullulan was therefore unavailable as a short-term (e.g. available within 3 hours) energy source and unavailable for characteristics associated with energy delivery (e.g. effect of glucose on satiety) . The unavailability of pullulan was also confirmed in our own in vitro experiments as shown in the Example. More than two thirds of pullulan remained unhydrolysed after a 3 hour incubation.
As a significant part of the pullulan seemed to be either resistant to degradation, or the digestion of pullulan occurred too slowly to achieve complete hydrolysis at the end of the small intestine these undigested carbohydrates reach the colon where they can be fermented by present micro-organisms and produce various gases. In their study, Wolf et al. (2003, vide supra) did find an increase in malabsorption (represented by the use of a hydrogen breath test) and in the incidence and frequency of flatulence. This is generally found when relatively high amounts of dietary fibres are ingested.
The reason for the low degree of hydrolysis is that pancreatic enzymes lack the specificity to break down the α-1,6 linkages of the polymer. We found that a reduction in the chain length of pullulan - by breaking part of the α-1,6 bonds via pretreatment by pullulanase - was more readily hydrolysable.
In vitro tests showed that not only the pretreated pullulan was degraded by amyloglucosidases, but also that with the degree of pretreatment the rate and extent of hydrolysis could be controlled. At all conditions the rate of hydrolysis was significantly slower than that of soluble starch in the
presence of both amylase and amyloglucosidase, so that a slow release of energy was obtained. Furthermore, almost all material was digested within 2 to 3 hours, depending on the amount/time of pullulanase used. Based on the high amount of energy that pullulan contains in the form of the glucose monomers pre-treated pullulan could potentially be an interesting dietary "slow-release" energy source.
Generation of pullulan fragments of predetermined chain lengths can be achieved in several ways. First, process control is an effective way to control the chain length of microbially produced pullulan. Although the exact mechanism of pullulan production is not known factors like, culture selection, cultivation techniques and control of incubation conditions, like pH or substrate are known to have a significant effect on the chain length distribution of biosynthetic pullulan. For instance, it is known that the presence of fructose in the culture medium promotes the production of high molecular weight pullulan. Another important factor is the harvest time, since early in the initial phases of biosynthesis high molecular weight pullulan with a wide chain length distribution is produced, while more pullulan of medium chain length and narrow chain length distribution is produced in the stationary growth phase. Alternatively pullulan with a specific chain length can be obtained by fractionation of crude material with a wider chain length distribution. This may be achieved by e.g. size exclusion techniques. Thirdly pullulan fragments with a defined chain length distribution can be obtained via partial hydrolysis of pullulan. For instance, pullulan P-200 (commercially available from Hayashibara Biochemical Laboratories, Japan) can be treated with the enzyme pullulanase that selectively hydrolyses alpha 1-6 bonds of the molecule. By careful control of the incubation conditions fractions with
desired chain length ranging from about 1,000 to 100,000 daltons can be obtained.
The specific type of pullulan used according to the present invention has a number average molecular weight between about 1,000 and 45,000 daltons, preferably between about 5,000 and 40,000 daltons. By average molecular weight, we mean in the context of the present invention the number average molecular weight (Mn), unless indicated otherwise. It is preferred that at least 70%, more preferably at least 90% of the pullulan molecules have a molecular weight of less than 45,000 Dalton.
Preferably, the pullulan is present in the food product in an amount of 0.005 to 35% by weight of the product, more preferably in an amount of 0.05 to 10% by weight of the product .
It is preferred that the food product according to the invention has a high moisture content. In particular, the water activity (Aw) is preferably at least 0.70.
Some examples of food products in accordance with the present invention (but not limiting to these) are: drinks / beverages, meal replacement products such as drinks, bars, powders, soups, dry soups, powdered soup concentrates, (fat) spreads, dressings, (whole) meals, desserts, sauces, sport drinks, fruit juices, snack foods, ready-to-eat and pre-packed meal products, ice creams and dried meal products. (Dry) soups are especially preferred.
The food products can be prepared by mixing the pullulan, in dry form or in the forms of an aqueous suspension, with the rest of the food product.
The food product of the present invention may optionally further comprise ingredients such as proteins, fats, salts, flavour components, colourants, emulsifiers, preservatives, acidifying agents and the like. The invention is illustrated in the following examples.
Example 1
Preparation of pullulan fragments and determination of molecular mass of fragments
A 2 % (w/w) solution of pullulan (PI20 from Hayashibara Company Ltd. Japan, MM = 200,000 Da) was made in 0.1 M sodium acetate pH 5.2 and heated for 5 minutes at 1000C. After cooling to room temperature the solution was divided into portions and to each portion different amounts of pullulanase (Prozyme from Novozyme) were added. Incubation was allowed to proceed for 7 hours at room temperature. The reaction was stopped by heating for 5 minutes at 1000C. The amount of reducing end groups liberated by the hydrolytic action of pullulanase was colourometrically determined by means of the dinitrosalicylic acid (DNSA) reaction using a maltotriose calibration curve. From these data the average chain length c/q the average molecular mass of fragments obtained was calculated (Table 1) .
Example 2
Colourimetric quantification of reducing end groups
Reducing end groups were measured with a method described by Bernfeld (Bernfeld, P., 1955, Amylases, α and β, Methods in Enzymology, Vol. 1, Academic Press, NY, 149-158) . Ten grams of 3, 5-dinitrosalicylic acid (DNSA) was dissolved in 200 ml 2 M NaCl and 500 ml H2O. Stirring and heating the suspension up to 600C promoted dissolving. After that, 300 g Rochelle salt (sodium potassium tartrate tetrahydrate) was added and the solution was adjusted to 1000 ml with H2O. The DNSA solution was kept from light at room temperature. 500 μl of samples to be analysed was added to 500 μl DNSA solution and heated for about 5 minutes at 1000C in a thermomixer (Eppendorf thermomixer comfort) . After that, tubes containing the mixtures were cooled under running tap water or on ice. Solutions were diluted properly with H2O and the absorbances were measured at 540 nm (Shimadzu) . Standard concentrations of maltose (ranging from 0- 5 mg/ml) were prepared in 0.02 M phosphate buffer pH 6.9, containing 0.067 M NaCl. From the absorbances measured, maltose concentrations were calculated.
Example 3
Rate of hydrolysis and fragment size
Pullulan was treated with pullulanase (0.0, 0.1 and 1.0 U/ml) as described above. To 14 ml of the samples 1 ml of amyloglucosidase (from Aspergillus niger, Fluka 10115) was added and glucose release was monitored in time. From Figure 2 it is clear that the unhydrolysed pullulan hardly released any glucose upon amyloglucosidase treatment, whereas the partially hydrolysed fractions of pullulan gave a sustained release of glucose over the two hours of incubation.
Example 4
Enzymatic glucose quantification
The glucose concentration of samples was measured using an enzymatic kit (Enzytec) . The measurement was based on the following principle: hexokinase D-glucose + ATf ► Glucose-6-phosphate + ΔDP
Glucose-6-phosphate-dehydrogenase Glucose-6-phosphate + NADP+ ► 6-PG + NADPH
+ H+
The reaction was performed in 3 ml plastic cuvettes. To 1 ml of triethanolamine (TEA) buffer of pH 7.6, containing
approximately 80 mg NADP and 190 mg ATP, 100 μl of sample or standard glucose solution was added, followed by 1.9 ml H2O. To the blank solution, 2 ml H2O was added. Solutions were mixed and after approximately 3 minutes the absorbance was measured at 340 nm against water. Then, 20 μl of a hexokinase/glucose-6- phosphate dehydrogenase suspension (200 U / 100 U) in ammonium sulfate was added to the solutions and solutions were mixed. After 10-15 minutes the absorbance was measured again and measurements were repeated after 2 minutes to check if the reactions had stopped. The glucose concentration of the samples was calculated with the following formula:
c = (V x Mw x ΔA) / (ε x d x v x 1000) [g glucose/1 sample solution] c = (3.020 x 180.16 x ΔA) / (6.3 x 1 x 0.1 x 1000) = 0.8636 x
ΔA [ g glucose/1 sample solution]
Claims
1. Carbohydrate containing food product having controlled energy release properties comprising a pullulan having a number average molecular weight between about 1,000 and 45,000 daltons .
2. Food product according to claim 1, wherein the pullulan has a number average molecular weight between about 5,000 and 40,000 daltons.
3. Food product according to any one of the preceding claims, wherein the pullulan is present in an amount of 0.005 to 35% by weight of the product.
4. Food product according to claim 3, wherein the pullulan is present in an amount of 0.05 to 10% by weight of the product.
5. Food product according to any one of the preceding claims, having a high moisture content.
6. Food product according to any one of the preceding claims, having a water activity (Aw) of at least 0.70.
7. Food product according to claim 6, in the form of a liquid product selected from the group consisting of sauces, soups and drinks .
8. Process for the preparation of a carbohydrate containing food product according to any one of the preceding claims, comprising the step of adding comprising a comprising adding a pullulan having a number average molecular weight between about 1,000 and 45,000 daltons to a food product and homogenising the obtained mixture.
***
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05077353.0 | 2005-10-14 | ||
EP05077353 | 2005-10-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007095977A1 true WO2007095977A1 (en) | 2007-08-30 |
Family
ID=35431379
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2006/009532 WO2007095977A1 (en) | 2005-10-14 | 2006-10-03 | Food product and process for preparing it |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007095977A1 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110166085A1 (en) * | 2008-04-29 | 2011-07-07 | Beck-Hoven Van Rudolf | Composition comprising carbohydrates and peptides which comprise tryptophan |
US20140205719A1 (en) | 2011-06-20 | 2014-07-24 | Generale Biscuit | Healthy layered cookie |
WO2015051228A1 (en) * | 2013-10-04 | 2015-04-09 | Monika Okoniewska | Soft biscuit with slowly available glucose |
CN107567279A (en) * | 2015-03-13 | 2018-01-09 | 大众饼干公司 | baked product |
US10568839B2 (en) | 2011-01-11 | 2020-02-25 | Capsugel Belgium Nv | Hard capsules |
US11319566B2 (en) | 2017-04-14 | 2022-05-03 | Capsugel Belgium Nv | Process for making pullulan |
US11576870B2 (en) | 2017-04-14 | 2023-02-14 | Capsugel Belgium Nv | Pullulan capsules |
US11889840B2 (en) | 2013-10-04 | 2024-02-06 | Generale Biscuit | Breakfast biscuit with slowly available glucose |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3875308A (en) * | 1972-01-13 | 1975-04-01 | Hayashibara Biochem Lab | Food compositions containing pullulan |
US4913925A (en) * | 1982-10-25 | 1990-04-03 | Yasutake Hiji | Foodstuff containing a hyperglycemia controlling agent |
EP0382355A2 (en) * | 1989-02-09 | 1990-08-16 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Growth promoting agent for bacteria containing pullulan and/or dextran |
US20030232067A1 (en) * | 2002-06-12 | 2003-12-18 | Wolf Bryan W. | Use of pullulan as a slowly digested carbohydrate |
WO2004023891A1 (en) * | 2002-09-13 | 2004-03-25 | Cerestar Holding B.V. | Slowly digestible carbohydrate materials for use in food and drink compositions |
-
2006
- 2006-10-03 WO PCT/EP2006/009532 patent/WO2007095977A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3875308A (en) * | 1972-01-13 | 1975-04-01 | Hayashibara Biochem Lab | Food compositions containing pullulan |
US4913925A (en) * | 1982-10-25 | 1990-04-03 | Yasutake Hiji | Foodstuff containing a hyperglycemia controlling agent |
EP0382355A2 (en) * | 1989-02-09 | 1990-08-16 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Growth promoting agent for bacteria containing pullulan and/or dextran |
US20030232067A1 (en) * | 2002-06-12 | 2003-12-18 | Wolf Bryan W. | Use of pullulan as a slowly digested carbohydrate |
WO2004023891A1 (en) * | 2002-09-13 | 2004-03-25 | Cerestar Holding B.V. | Slowly digestible carbohydrate materials for use in food and drink compositions |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110166085A1 (en) * | 2008-04-29 | 2011-07-07 | Beck-Hoven Van Rudolf | Composition comprising carbohydrates and peptides which comprise tryptophan |
US10172375B2 (en) * | 2008-04-29 | 2019-01-08 | Dsm Ip Assets B.V. | Compositions comprising carbohydrates and peptides which comprise tryptophan |
US10568839B2 (en) | 2011-01-11 | 2020-02-25 | Capsugel Belgium Nv | Hard capsules |
US9883679B2 (en) | 2011-06-20 | 2018-02-06 | Generale Biscuit | Biscuit dough |
US20140205719A1 (en) | 2011-06-20 | 2014-07-24 | Generale Biscuit | Healthy layered cookie |
US10357041B2 (en) | 2011-06-20 | 2019-07-23 | Generale Biscuit | Healthy layered cookie |
US10306897B2 (en) | 2011-06-20 | 2019-06-04 | Generale Biscuit | Breakfast biscuit with slowly available glucose |
US20160249627A1 (en) * | 2013-10-04 | 2016-09-01 | Generale Biscuit | Soft biscuit with slowly available glucose |
RU2638946C2 (en) * | 2013-10-04 | 2017-12-19 | Женераль Бискит | Soft biscuits with slow release of glucose |
CN105578886A (en) * | 2013-10-04 | 2016-05-11 | 大众饼干公司 | Soft biscuit with slowly available glucose |
WO2015051228A1 (en) * | 2013-10-04 | 2015-04-09 | Monika Okoniewska | Soft biscuit with slowly available glucose |
US11889840B2 (en) | 2013-10-04 | 2024-02-06 | Generale Biscuit | Breakfast biscuit with slowly available glucose |
US11896016B2 (en) * | 2013-10-04 | 2024-02-13 | Generale Biscuit | Soft biscuit with slowly available glucose |
CN107567279A (en) * | 2015-03-13 | 2018-01-09 | 大众饼干公司 | baked product |
US11096393B2 (en) | 2015-03-13 | 2021-08-24 | Generale Biscuit | Bakery product |
US11319566B2 (en) | 2017-04-14 | 2022-05-03 | Capsugel Belgium Nv | Process for making pullulan |
US11576870B2 (en) | 2017-04-14 | 2023-02-14 | Capsugel Belgium Nv | Pullulan capsules |
US11878079B2 (en) | 2017-04-14 | 2024-01-23 | Capsugel Belgium Nv | Pullulan capsules |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6217673B2 (en) | Branched dextrin, method for producing the same, and food and drink | |
Butterworth et al. | Human α‐amylase and starch digestion: An interesting marriage | |
Crowe et al. | Inhibition of enzymic digestion of amylose by free fatty acids in vitro contributes to resistant starch formation | |
EP1901615A2 (en) | Food product and process for preparing it | |
Behall et al. | Effect of starch structure on glucose and insulin responses in adults | |
WO2007095977A1 (en) | Food product and process for preparing it | |
AU2003204155B8 (en) | Slowly digestable starch product | |
US6929817B2 (en) | Slowly digestible starch product | |
US7612198B2 (en) | Soluble highly branched glucose polymers | |
US20100099864A1 (en) | Novel slowly digestible storage carbohydrate | |
WO2005025327A2 (en) | Resistant starch with cooking properties similar to untreated starch | |
Meyer | Nondigestible oligosaccharides as dietary fiber | |
Śliżewska et al. | Resistant dextrins as prebiotic | |
Toraya-Avilés et al. | Some nutritional characteristics of enzymatically resistant maltodextrin from cassava (Manihot esculenta Crantz) starch | |
Ibrahim | Technological aspects of fructo-oligosaccharides (FOS), production processes, physiological properties, applications and health benefits | |
US20120231150A1 (en) | Digestive Enzyme Inhibitor and Methods of Use | |
Li et al. | Identification of the key structure, preparation conditions and properties of resistant dextrin for indigestibility based on simulated gastrointestinal conditions | |
Roder et al. | Starch molecular and nutritional properties: a review | |
Goesaert et al. | Use of enzymes in the production of cereal-based functional foods and food ingredients | |
EP2057906B1 (en) | Pectin-modified resistant starch, a composition containing the same and method for preparing resistant starch | |
Emmambux et al. | Starch: Nutritional and health aspects | |
Jiang et al. | Progress in understanding resistant-starch formation in hydroxypropyl starch: A minireview | |
Nofrarías et al. | Potential health benefits of potato starch | |
BUCK | Resistant Maltodextrin Overview | |
Laurentin | Starch pyrodextrins: in vitro fermentation and physiological effects |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06805980 Country of ref document: EP Kind code of ref document: A1 |